Ex-CEO Sued by New York for Insider Trading Tied to COVID-19 Vaccine Contamination

New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading

Attorney General Letitia James of New York filed an insider trading lawsuit on Thursday against a former biotech chief executive, accusing him of turning a $7.6 million profit on the sale of the company’s stock before the public learned that millions of doses of a Covid-19 vaccine were contaminated. Filed in a New York State court, the lawsuit said that Robert G. Kramer, who was the chief executive of Emergent BioSolutions, knew of the systemic …

Ex-CEO sued by New York for insider trading tied to COVID-19 vaccine contamination

By Jonathan Stempel NEW YORK, Jan 15 (Reuters) – A former chief executive of Emergent BioSolutions was charged on Thursday with insider trading by New York Attorney General Letitia James for ‍allegedly selling the contract drug manufacturer’s stock while knowing about contamination problems at a Baltimore plant that made COVID-19 vaccines. Robert Kramer was accused in the civil lawsuit of violating the Martin Act, a powerful state securities law…

Former Emergent BioSolutions CEO sued for insider trading, company reaches $900K settlement in N.Y.

The former chief executive officer of Emergent BioSolutions was accused of insider trading by the New York State attorney general in connection with a contract the company had to manufacture a Covid-19 vaccine for AstraZeneca. Robert Kramer allegedly sold more than $10 million worth of Emergent stock after becoming aware of contamination problems that made millions of doses of the vaccines unusable, but before the information was disclosed publi…

New York sues former Emergent CEO for alleged insider trading during Covid vaccine struggles

New York prosecutors sued the former CEO of Emergent BioSolutions over alleged insider trading while the contract manufacturer struggled with contamination issues making AstraZeneca's Covid-19 vaccine during the pandemic. The lawsuit ...